pneumocystis pneumonia

Trimethoprim (NSC-106568) is a Dihydrofolate Reductase Inhibitor Antibacterial. The mechanism of action of trimethoprim is as a Dihydrofolate Reductase Inhibitor, and Cytochrome P450 2C8 Inhibitor, and Organic Cation Transporter 2 Inhibitor.

Pentamidine dihydrochloride (MP-601205 dihydrochloride) is an aromatic diamidine agent effective against various microorganisms, including protozoa (Trypanosoma brucei, Leishmania spp., and Babesia spp.) and fungi (Pneumocystis jirovecii). It is a potent and selective inhibitor of protein tyrosine phosphatases and phosphatase of regenerating liver. Pentamidine dihydrochloride inhibits the parasite Leishmania infantum with an IC50 of 2.5 μM.

Pentamidine is an antifungal and antiprotozoal agent, interacting directly with the pathogen genome by binding to AT-rich regions of duplex DNA and the minor groove of DNA, thereby interfering with DNA replication.

Atovaquone-D4 is the deuterium-labeled Atovaquone. Atovaquone (T1491) is a medication used to treat or prevent pneumocystis babesia, malaria, toxoplasmosis, and pneumonia.

l-Primaquine is used to treat and prevent malaria and to treat Pneumocystis pneumonia.

Trimethoprim hydrochloride, a bacteriostatic antibiotic and dihydrofolate reductase inhibitor, demonstrates efficacy against a broad spectrum of Gram-positive and Gram-negative aerobic bacteria. It has research applications for urinary tract infections, Shigellosis, and Pneumocystis pneumonia. Additionally, when combined with zinc, it can inhibit the infection of Influenza A virus in chick embryos [1] [2] [3] [4].

Trimethoprim-D9 is the deuterated form of Trimethoprim. Trimethoprim (T1153) is a bacteriostatic antibiotic and an orally active inhibitor of dihydrofolate reductase. It shows activity against a variety of Gram-positive and Gram-negative aerobic bacteria. Trimethoprim (T1153) is used in studies involving urinary tract infections, shigellosis, and Pneumocystis pneumonia.

Trimethoprim-13C3 is a 13C-labeled variant of Trimethoprim. Trimethoprim (T1153) is an antibacterial antibiotic and an orally active inhibitor of dihydrofolate reductase. It is effective against a variety of Gram-positive and Gram-negative aerobic bacteria. Trimethoprim (T1153) holds potential for studying urinary tract infections, shigellosis, and pneumocystis pneumonia. When combined with zinc, Trimethoprim (T1153) can inhibit influenza A virus in chicken embryos.

Trimethoprim-D3 is the deuterated form of Trimethoprim. Trimethoprim is a bacteriostatic antibiotic and an orally active inhibitor of dihydrofolate reductase. It is effective against a range of Gram-positive and Gram-negative aerobic bacteria. Trimethoprim is utilized in the study of urinary tract infections, shigellosis, and Pneumocystis pneumonia.

Trimethoprim-D3 (Standard) is a reference standard of Trimethoprim-D3 intended for quantitative analysis, quality control, and related biochemical research applications. Trimethoprim-d3 is the deuterated form of Trimethoprim. Trimethoprim is a bacteriostatic antibiotic and an orally active inhibitor of dihydrofolate reductase. It is effective against a range of Gram-positive and Gram-negative aerobic bacteria. Trimethoprim is utilized in the study of urinary tract infections, shigellosis, and Pneumocystis pneumonia.

Trimethoprim-D9 (Standard) is a reference standard of Trimethoprim-D9 intended for quantitative analysis, quality control, and related biochemical research applications. Trimethoprim-d9 is the deuterated form of Trimethoprim. Trimethoprim is a bacteriostatic antibiotic and an orally active inhibitor of dihydrofolate reductase. It shows activity against a variety of Gram-positive and Gram-negative aerobic bacteria. Trimethoprim is used in studies involving urinary tract infections, shigellosis, and Pneumocystis pneumonia.